Flexion

FLXN NASDAQ
11.07
-0.04
-0.36%
After Hours: 11.07 0 0.00% 16:41 08/23 EDT
Open
11.01
Prev Close
11.11
High
11.47
Low
10.83
Volume
389.73K
Avg Vol (3M)
565.63K
52 Week High
23.10
52 Week Low
8.76
% Turnover
1.02%
Market Cap
421.84M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Flexion FLXN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Flexion Therapeutics, Inc. is a United States-based specialty pharmaceutical company. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product candidate, Zilretta, is a late-stage, injectable, extended-release, intra-articular (IA) investigational steroid. The Company is developing Zilretta as a treatment for patients with moderate to severe OA knee pain. The Company has specifically designed Zilretta to combine a steroid, triamcinolone acetonide (TCA) with poly lactic-co-glycolic acid (PLGA), for providing sustained therapeutic concentrations in the joint and persistent analgesic effect. The Company's other product candidates include FX007 for post-operative pain and FX005 for the treatment of end-stage OA patients. The Company is engaged in conducting a Phase IIb clinical trial of Zilretta.
MORE >

Recently

Name
Price
%Change